Center on Health Equity & Access

Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS.

A cohort study found lower breast cancer screening odds in the most redlined census tracts, independent of present-day social vulnerability.

An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and education can close gaps.

In this Director’s Cut episode of Managed Care Cast, we speak with Surbhi Sidana, MD, Stanford University, on the transformation of the myeloma field.

Experts discuss what SCAN Health Plan's new Medicare Advantage (MA) partnership with Costco could mean for beneficiaries, competition, and costs.

This extension to smaller drugmakers addresses a gap that has increasingly drawn attention from policy watchers.

Traveling a greater distance for cataract surgery significantly lowered the odds of receiving it, with each 100 miles cutting odds by 14% overall.

Transplant weight-loss access, a new dermatomyositis drug, mifepristone safety views, and racial gaps in cataract surgery and CRC mortality.

DOJ policy shifts have put HHS on the same side as states seeking to narrow Section 504's disability integration mandate in Texas v Kennedy.

In this analysis, all 4 biologic classes showed reduced risk, and the CV benefit remained consistent across White, Black, and Asian patients.

At a Chicago roundtable, clinicians detailed fragmented obesity and diabetes care, transplant-access barriers, and insurance-driven prescribing decisions.

FDA approves brepocitinib, the first oral, targeted therapy for adult dermatomyositis, backed by phase 3 VALOR data.

Atlanta clinicians described obesity care that stalls between routine diagnosis and delayed treatment, with coverage rules driving therapy choices.

County-level CRC mortality fell substantially since 2000, but some counties still had rates more than 13 times the Healthy People 2030 target in 2019.

A poll finds awareness of the mifepristone abortion pill is rising, but safety doubts and legal battles persist.

Nearly 1 in 3 women aged 21 to 29 and 1 in 7 aged 30 to 65 had never been screened for cervical cancer by 2023.

Mark Makhinson, PharmD, launches Future-Proofing Pharmacy, exploring AI, access, and the health-system pharmacy enterprise of 2035.

Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs.

Authors noted that a grocery assistance benefit in commercial health plans was linked to fewer diabetes complications and improved medication adherence.

Clinicians outline fragmented obesity and diabetes care models, insurance-driven prescribing, and early results from Medicare's GLP-1 bridge program.

CMS is funding 138 grants worth $144M to expand rural mental health, maternal, and emergency care access across Alabama.

Lifetime colorectal cancer (CRC) risk was highest in highly developed countries, according to a global population-based study.

Self-compassion partly explains why shame over visible skin conditions leads to depression and anxiety, a new study finds.

Hospice use and higher-intensity care are less common among older adults in isolated rural areas than in urban areas, highlighting rural hospice gaps.

Addressing unmet campus mental health needs supports student academic performance while promoting long-term health equity and affordability.